Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Sam1832 who wrote (11866)	4/5/2013 11:07:53 AM
From: NTTG	2 Recommendations Respond to of 13111

I was talking about investors, but if a buyer does come along..... what are the odds that residual value would be offered......all these years without a partner or development deal, and little cash in the bank does not bode well for negotiations beyond a juicy deal for MGT....This could be a cheap buy for a billion dollar portfolio interested in extending their existing patent life through an innocuous combination strategy, but no need to pay a premium for that.